The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial

NCT00187408 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Deep Vein Thrombosis
Pulmonary Embolism

Interventions

DRUG: Low Molecular Weight Heparin (dalteparin)

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]
[object Object]